In-vitro activity of LY146032 against Staphylococcus aureus and S. epidermidis

Publisher Website
Google Scholar
Abstract
The antibacterial activity of LY146032, a new cyclic polypeptide, was compared with that of vancomycin against 163 isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus and S. epidermidis. The MICs of LY 146032 and vancomycin for 90% of the isolates were 10 mg/l and 2.0—4.0 mg/l, respectively. Interpretative guidelines for 15 μg and 30 μg LY146032 discs could not be established because all isolates tested were susceptible to LY146032, on the basis of achievable serum levels. With one exception, MBC to MIC ratios of LY146032 and vancomycin were ≤ 2. Inoculum size had minimal effect on ratios. In time-kill studies, both drugs were 99.9% bactericidal at 6 h for four isolates at concentrations four times the MBC or less. No change in LY146032 activity was observed between isogenic pairs that were resistant to other antibiotics. Thus, LY146032 was very active in vitro against all staphylococcal isolates.

This publication has 2 references indexed in Scilit: